SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Addus HomeCare Corporation (ADUS) trades at a trailing P/E of 17.7, forward P/E of 13.5. Trailing earnings yield is 5.66%, forward earnings yield 7.39%. PEG 0.76 (Peter Lynch undervalued ≤1.0). Graham Number is $82.96.
Criteria proven by this page:
- VALUE (62/100, Pass) — P/E is below market average (17.7); PEG ≤ 1.0 — Peter Lynch undervalued (0.76); analyst target implies upside (+38%); earnings yield beats bond yields (5.66%).
- Forward P/E 13.5 (down from trailing 17.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.76 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 5.66% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 7.39% as earnings recover.
- Analyst consensus target $128.67 (+38% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 78/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
62/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ADUS
Valuation Multiples
P/E (TTM)17.7
Forward P/E13.5
PEG Ratio0.76
Forward PEG0.42
P/B Ratio1.56
P/S Ratio1.20
EV/EBITDA11.8
Per Share Data
EPS (TTM)$5.20
Forward EPS (Est.)$6.89
Book Value / Share$58.83
Revenue / Share$77.11
FCF / Share$5.63
Yields & Fair Value
Earnings Yield5.66%
Forward Earnings Yield7.39%
Dividend Yield0.00%
Graham Number$82.96
SharesGrow IV$185.92 (+99.4%)
Analyst Target$128.67 (+38%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
32.9 |
-34.56 |
2.49 |
0.99 |
- |
| 2017 |
29.3 |
2.35 |
2.26 |
0.94 |
- |
| 2018 |
50.9 |
3.72 |
3.23 |
1.72 |
- |
| 2019 |
53.2 |
1.42 |
2.82 |
2.07 |
- |
| 2020 |
55.9 |
3.53 |
3.57 |
2.42 |
- |
| 2021 |
32.6 |
0.92 |
2.56 |
1.70 |
- |
| 2022 |
34.9 |
33.35 |
2.53 |
1.69 |
- |
| 2023 |
24.1 |
0.69 |
2.13 |
1.42 |
- |
| 2024 |
29.0 |
2.70 |
2.20 |
1.85 |
- |
| 2025 |
20.7 |
1.04 |
1.83 |
1.39 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.04 |
$400.69M |
$12.02M |
3% |
| 2017 |
$1.17 |
$425.72M |
$13.61M |
3.2% |
| 2018 |
$1.33 |
$518.12M |
$17.5M |
3.4% |
| 2019 |
$1.77 |
$648.79M |
$25.24M |
3.9% |
| 2020 |
$2.08 |
$764.78M |
$33.13M |
4.3% |
| 2021 |
$2.81 |
$864.5M |
$45.13M |
5.2% |
| 2022 |
$2.84 |
$951.12M |
$46.03M |
4.8% |
| 2023 |
$3.83 |
$1.06B |
$62.52M |
5.9% |
| 2024 |
$4.23 |
$1.15B |
$73.6M |
6.4% |
| 2025 |
$5.21 |
$1.42B |
$95.91M |
6.7% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$6.89 |
$6.79 – $6.94 |
$1.52B |
$1.5B – $1.53B |
9 |
| 2027 |
$7.44 |
$7.34 – $7.54 |
$1.59B |
$1.56B – $1.61B |
9 |
| 2028 |
$8.08 |
$7.00 – $8.93 |
$1.66B |
$1.66B – $1.66B |
3 |
